Blockade of THBS1 has been shown to mitigate hyperglycemia-induced peritoneal fibrosis (88), while inhibition of THBS1-dependent TGF-β activation reduces renal injury and proteinuria in mouse models of diabetic nephropathy (89). Here, THBS1 is linked to Hyperglycemia.